Transparent development of the WHO rapid advice guidelines

Holger J. Schünemann, Suzanne R. Hill, Meetali Kakad, Gunn E. Vist, Richard Bellamy, Lauren Stockman, Torbjørn Fosen Wisløff, Chris Del Del Mar, Frederick Hayden, Timothy M. Uyeki, Jeremy Farrar, Yazdan Yazdanpanah, Howard Zucker, John Beigel, Tawee Chotpitayasunondh, Tinh Hien Tran, Bülent Özbay, Norio Sugaya, Andrew D. Oxman

Research output: Contribution to journalReview articleResearchpeer-review

92 Citations (Scopus)

Abstract

Emerging health problems require rapid advice. We describe the development and pilot testing of a systematic, transparent approach used by the World Health Organization (WHO) to develop rapid advice guidelines in response to requests from member states confronted with uncertainty about the pharmacological management of avian influenza A (H5N1) virus infection. We first searched for systematic reviews of randomized trials of treatment and prevention of seasonal influenza and for non-trial evidence on H5N1 infection, including case reports and animal and in vitro studies. A panel of clinical experts, clinicians with experience in treating patients with H5N1, influenza researchers, and methodologists was convened for a two-day meeting. Panel members reviewed the evidence prior to the meeting and agreed on the process. It took one month to put together a team to prepare the evidence profiles (i.e., summaries of the evidence on important clinical and policy questions), and it took the team only five weeks to prepare and revise the evidence profiles and to prepare draft guidelines prior to the panel meeting. A draft manuscript for publication was prepared within 10 days following the panel meeting. Strengths of the process include its transparency and the short amount of time used to prepare these WHO guidelines. The process could be improved by shortening the time required to commission evidence profiles. Further development is needed to facilitate stakeholder involvement, and evaluate and ensure the guideline's usefulness.

Original languageEnglish
Pages (from-to)786-793
Number of pages8
JournalPLoS Medicine
Volume4
Issue number5
DOIs
Publication statusPublished - May 2007

Fingerprint

Guidelines
Human Influenza
H5N1 Subtype Influenza A Virus
Influenza in Birds
Manuscripts
Influenza A virus
Virus Diseases
Uncertainty
Publications
Research Personnel
Pharmacology
Health
Infection
Therapeutics
In Vitro Techniques

Cite this

Schünemann, H. J., Hill, S. R., Kakad, M., Vist, G. E., Bellamy, R., Stockman, L., ... Oxman, A. D. (2007). Transparent development of the WHO rapid advice guidelines. PLoS Medicine, 4(5), 786-793. https://doi.org/10.1371/journal.pmed.0040119
Schünemann, Holger J. ; Hill, Suzanne R. ; Kakad, Meetali ; Vist, Gunn E. ; Bellamy, Richard ; Stockman, Lauren ; Wisløff, Torbjørn Fosen ; Del Mar, Chris Del ; Hayden, Frederick ; Uyeki, Timothy M. ; Farrar, Jeremy ; Yazdanpanah, Yazdan ; Zucker, Howard ; Beigel, John ; Chotpitayasunondh, Tawee ; Tran, Tinh Hien ; Özbay, Bülent ; Sugaya, Norio ; Oxman, Andrew D. / Transparent development of the WHO rapid advice guidelines. In: PLoS Medicine. 2007 ; Vol. 4, No. 5. pp. 786-793.
@article{5af5aca4ed754067a2e2f975c085b7af,
title = "Transparent development of the WHO rapid advice guidelines",
abstract = "Emerging health problems require rapid advice. We describe the development and pilot testing of a systematic, transparent approach used by the World Health Organization (WHO) to develop rapid advice guidelines in response to requests from member states confronted with uncertainty about the pharmacological management of avian influenza A (H5N1) virus infection. We first searched for systematic reviews of randomized trials of treatment and prevention of seasonal influenza and for non-trial evidence on H5N1 infection, including case reports and animal and in vitro studies. A panel of clinical experts, clinicians with experience in treating patients with H5N1, influenza researchers, and methodologists was convened for a two-day meeting. Panel members reviewed the evidence prior to the meeting and agreed on the process. It took one month to put together a team to prepare the evidence profiles (i.e., summaries of the evidence on important clinical and policy questions), and it took the team only five weeks to prepare and revise the evidence profiles and to prepare draft guidelines prior to the panel meeting. A draft manuscript for publication was prepared within 10 days following the panel meeting. Strengths of the process include its transparency and the short amount of time used to prepare these WHO guidelines. The process could be improved by shortening the time required to commission evidence profiles. Further development is needed to facilitate stakeholder involvement, and evaluate and ensure the guideline's usefulness.",
author = "Sch{\"u}nemann, {Holger J.} and Hill, {Suzanne R.} and Meetali Kakad and Vist, {Gunn E.} and Richard Bellamy and Lauren Stockman and Wisl{\o}ff, {Torbj{\o}rn Fosen} and {Del Mar}, {Chris Del} and Frederick Hayden and Uyeki, {Timothy M.} and Jeremy Farrar and Yazdan Yazdanpanah and Howard Zucker and John Beigel and Tawee Chotpitayasunondh and Tran, {Tinh Hien} and B{\"u}lent {\"O}zbay and Norio Sugaya and Oxman, {Andrew D.}",
year = "2007",
month = "5",
doi = "10.1371/journal.pmed.0040119",
language = "English",
volume = "4",
pages = "786--793",
journal = "PLoS Medicine",
issn = "1549-1277",
publisher = "Public Library of Science",
number = "5",

}

Schünemann, HJ, Hill, SR, Kakad, M, Vist, GE, Bellamy, R, Stockman, L, Wisløff, TF, Del Mar, CD, Hayden, F, Uyeki, TM, Farrar, J, Yazdanpanah, Y, Zucker, H, Beigel, J, Chotpitayasunondh, T, Tran, TH, Özbay, B, Sugaya, N & Oxman, AD 2007, 'Transparent development of the WHO rapid advice guidelines' PLoS Medicine, vol. 4, no. 5, pp. 786-793. https://doi.org/10.1371/journal.pmed.0040119

Transparent development of the WHO rapid advice guidelines. / Schünemann, Holger J.; Hill, Suzanne R.; Kakad, Meetali; Vist, Gunn E.; Bellamy, Richard; Stockman, Lauren; Wisløff, Torbjørn Fosen; Del Mar, Chris Del; Hayden, Frederick; Uyeki, Timothy M.; Farrar, Jeremy; Yazdanpanah, Yazdan; Zucker, Howard; Beigel, John; Chotpitayasunondh, Tawee; Tran, Tinh Hien; Özbay, Bülent; Sugaya, Norio; Oxman, Andrew D.

In: PLoS Medicine, Vol. 4, No. 5, 05.2007, p. 786-793.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Transparent development of the WHO rapid advice guidelines

AU - Schünemann, Holger J.

AU - Hill, Suzanne R.

AU - Kakad, Meetali

AU - Vist, Gunn E.

AU - Bellamy, Richard

AU - Stockman, Lauren

AU - Wisløff, Torbjørn Fosen

AU - Del Mar, Chris Del

AU - Hayden, Frederick

AU - Uyeki, Timothy M.

AU - Farrar, Jeremy

AU - Yazdanpanah, Yazdan

AU - Zucker, Howard

AU - Beigel, John

AU - Chotpitayasunondh, Tawee

AU - Tran, Tinh Hien

AU - Özbay, Bülent

AU - Sugaya, Norio

AU - Oxman, Andrew D.

PY - 2007/5

Y1 - 2007/5

N2 - Emerging health problems require rapid advice. We describe the development and pilot testing of a systematic, transparent approach used by the World Health Organization (WHO) to develop rapid advice guidelines in response to requests from member states confronted with uncertainty about the pharmacological management of avian influenza A (H5N1) virus infection. We first searched for systematic reviews of randomized trials of treatment and prevention of seasonal influenza and for non-trial evidence on H5N1 infection, including case reports and animal and in vitro studies. A panel of clinical experts, clinicians with experience in treating patients with H5N1, influenza researchers, and methodologists was convened for a two-day meeting. Panel members reviewed the evidence prior to the meeting and agreed on the process. It took one month to put together a team to prepare the evidence profiles (i.e., summaries of the evidence on important clinical and policy questions), and it took the team only five weeks to prepare and revise the evidence profiles and to prepare draft guidelines prior to the panel meeting. A draft manuscript for publication was prepared within 10 days following the panel meeting. Strengths of the process include its transparency and the short amount of time used to prepare these WHO guidelines. The process could be improved by shortening the time required to commission evidence profiles. Further development is needed to facilitate stakeholder involvement, and evaluate and ensure the guideline's usefulness.

AB - Emerging health problems require rapid advice. We describe the development and pilot testing of a systematic, transparent approach used by the World Health Organization (WHO) to develop rapid advice guidelines in response to requests from member states confronted with uncertainty about the pharmacological management of avian influenza A (H5N1) virus infection. We first searched for systematic reviews of randomized trials of treatment and prevention of seasonal influenza and for non-trial evidence on H5N1 infection, including case reports and animal and in vitro studies. A panel of clinical experts, clinicians with experience in treating patients with H5N1, influenza researchers, and methodologists was convened for a two-day meeting. Panel members reviewed the evidence prior to the meeting and agreed on the process. It took one month to put together a team to prepare the evidence profiles (i.e., summaries of the evidence on important clinical and policy questions), and it took the team only five weeks to prepare and revise the evidence profiles and to prepare draft guidelines prior to the panel meeting. A draft manuscript for publication was prepared within 10 days following the panel meeting. Strengths of the process include its transparency and the short amount of time used to prepare these WHO guidelines. The process could be improved by shortening the time required to commission evidence profiles. Further development is needed to facilitate stakeholder involvement, and evaluate and ensure the guideline's usefulness.

UR - http://www.scopus.com/inward/record.url?scp=34249672390&partnerID=8YFLogxK

U2 - 10.1371/journal.pmed.0040119

DO - 10.1371/journal.pmed.0040119

M3 - Review article

VL - 4

SP - 786

EP - 793

JO - PLoS Medicine

JF - PLoS Medicine

SN - 1549-1277

IS - 5

ER -

Schünemann HJ, Hill SR, Kakad M, Vist GE, Bellamy R, Stockman L et al. Transparent development of the WHO rapid advice guidelines. PLoS Medicine. 2007 May;4(5):786-793. https://doi.org/10.1371/journal.pmed.0040119